Literature DB >> 10548572

Antibiotics modulate vaccine-induced humoral immune response.

P C Woo1, H W Tsoi, L P Wong, H C Leung, K Y Yuen.   

Abstract

The effects of antibiotics on the antigen-specific humoral immune response are not known. Macrolides, tetracyclines, and beta-lactams are commonly prescribed antibiotics. The first two are known to have immunomodulatory activities. The effects of clarithromycin, doxycycline, and ampicillin on the primary and secondary antibody responses to tetanus toxoid, a pneumococcal polysaccharide vaccine, a hepatitis B virus surface antigen (HBsAg) vaccine, and live attenuated Salmonella typhi (Ty21a) were investigated using a mouse model. For the mice receiving the tetanus toxoid, the immunoglobulin M (IgM) level of the clarithromycin group at day 7 was significantly lower than the corresponding antibody level of the normal saline (NS) group. For the mice receiving the pneumococcal polysaccharide vaccine, the total antibody and IgM levels of the clarithromycin group and the IgM level of the doxycycline group at day 7 were significantly lower than the corresponding antibody levels of the ampicillin and NS groups. For the mice receiving the HBsAg vaccine, the IgM level of the doxycycline group at day 7 was significantly lower than the corresponding antibody levels of the clarithromycin and NS groups, while the IgM level of the clarithromycin group at day 28 was significantly lower than the corresponding antibody levels of the doxycycline, ampicillin, and NS groups. For the mice receiving all three vaccines, there were no statistically significant differences between any of the antibody levels of the ampicillin group and the corresponding antibody levels of the NS group. For the mice receiving Ty21a, the total antibody levels of the ampicillin group at days 7 and 21 were significantly higher than the corresponding antibody levels of the NS group. Moreover, the IgM levels of the clarithromycin, doxycycline, and ampicillin groups at days 7 and 21 were significantly higher than the corresponding antibody levels of the NS group. Furthermore, the total antibody level of the ampicillin group at day 21 was significantly higher than the corresponding antibody level of the doxycycline group. For all four vaccines, there were no statistically significant differences among the serum levels of interleukin-10 and gamma interferon for the mice treated with the various antibiotics. We conclude that clarithromycin and doxycycline, but not ampicillin, suppress the antibody responses of mice to T-cell-dependent and T-cell-independent antigens, whereas all three antibiotics enhance the antibody response to live attenuated mucosal bacterial vaccines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548572      PMCID: PMC95784          DOI: 10.1128/CDLI.6.6.832-837.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  27 in total

1.  IgG antibody reactive with five serotypes of Streptococcus pneumoniae in commercial intravenous immunoglobulin preparations.

Authors:  R J Hamill; D M Musher; J E Groover; P J Zavell; D A Watson
Journal:  J Infect Dis       Date:  1992-07       Impact factor: 5.226

2.  Differential sensitivity of human T helper cell pathways by in vitro exposure to cyclosporin A.

Authors:  M Clerici; G M Shearer
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

3.  Comparative effects of roxithromycin and erythromycin on cellular immune functions in vitro. 3. Killing of intracellular Staphylococcus aureus by human macrophages.

Authors:  A M Cuffini; N A Carlone; V Tullio; M Borsotto
Journal:  Microbios       Date:  1989

4.  A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results.

Authors:  M H Wahdan; C Sérié; Y Cerisier; S Sallam; R Germanier
Journal:  J Infect Dis       Date:  1982-03       Impact factor: 5.226

5.  Comparative effects of roxithromycin and erythromycin on cellular immune functions in vitro. 2. Chemotaxis and phagocytosis of 3H-Staphylococcus aureus by human macrophages.

Authors:  N A Carlone; A M Cufini; V Tullio; D Sassella
Journal:  Microbios       Date:  1989

6.  Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages.

Authors:  K Takeshita; I Yamagishi; M Harada; S Otomo; T Nakagawa; Y Mizushima
Journal:  Drugs Exp Clin Res       Date:  1989

7.  Reactivity and protective capacity of a polyclonal antiserum derived from mice immunized with antibiotic exposed Escherichia coli.

Authors:  G Raponi; M T Lun; G Lorino; C Nazzari; A Gaeta; C Mancini; F Filadoro
Journal:  J Antimicrob Chemother       Date:  1993-01       Impact factor: 5.790

8.  Erythromycin promotes monocyte to macrophage differentiation.

Authors:  N Keicho; S Kudoh; H Yotsumoto; K S Akagawa
Journal:  J Antibiot (Tokyo)       Date:  1994-01       Impact factor: 2.649

9.  A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report.

Authors:  W Szmuness; C E Stevens; E A Zang; E J Harley; A Kellner
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

10.  Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis.

Authors:  H Nagai; H Shishido; R Yoneda; E Yamaguchi; A Tamura; A Kurashima
Journal:  Respiration       Date:  1991       Impact factor: 3.580

View more
  18 in total

Review 1.  Immuno-modulation and anti-inflammatory benefits of antibiotics: the example of tilmicosin.

Authors:  André G Buret
Journal:  Can J Vet Res       Date:  2010-01       Impact factor: 1.310

Review 2.  Factors That Influence the Immune Response to Vaccination.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2019-03-13       Impact factor: 26.132

3.  Enhancement by ampicillin of antibody responses induced by a protein antigen and a DNA vaccine carried by live-attenuated Salmonella enterica serovar Typhi.

Authors:  P C Woo; H W Tsoi; H C Leung; L P Wong; S S Wong; E Chan; K Y Yuen
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

4.  Clarithromycin attenuates mastectomy-induced acute inflammatory response.

Authors:  L W Chow; K Y Yuen; P C Woo; W I Wei
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

Review 5.  The potential of the microbiota to influence vaccine responses.

Authors:  David J Lynn; Bali Pulendran
Journal:  J Leukoc Biol       Date:  2017-12-28       Impact factor: 4.962

6.  Determination of serum IgG antibodies to Bacillus anthracis protective antigen in environmental sampling workers using a fluorescent covalent microsphere immunoassay.

Authors:  R E Biagini; D L Sammons; J P Smith; E H Page; J E Snawder; C A F Striley; B A MacKenzie
Journal:  Occup Environ Med       Date:  2004-08       Impact factor: 4.402

7.  Non-therapeutic administration of a model antimicrobial growth promoter modulates intestinal immune responses.

Authors:  Estela Costa; Richard Re Uwiera; John P Kastelic; L Brent Selinger; G Douglas Inglis
Journal:  Gut Pathog       Date:  2011-09-25       Impact factor: 4.181

8.  Killed Whole-Cell Oral Cholera Vaccine Induces CCL20 Secretion by Human Intestinal Epithelial Cells in the Presence of the Short-Chain Fatty Acid, Butyrate.

Authors:  Ju-Ri Sim; Seok-Seong Kang; Daesang Lee; Cheol-Heui Yun; Seung Hyun Han
Journal:  Front Immunol       Date:  2018-01-29       Impact factor: 7.561

9.  What is the true in vitro potency of oxytetracycline for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida?

Authors:  L Dorey; S Hobson; P Lees
Journal:  J Vet Pharmacol Ther       Date:  2017-01-18       Impact factor: 1.786

10.  Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.

Authors:  Conrad P Quinn; Vera A Semenova; Cheryl M Elie; Sandra Romero-Steiner; Carolyn Greene; Han Li; Karen Stamey; Evelene Steward-Clark; Daniel S Schmidt; Elizabeth Mothershed; Janet Pruckler; Stephanie Schwartz; Robert F Benson; Leta O Helsel; Patricia F Holder; Scott E Johnson; Molly Kellum; Trudy Messmer; W Lanier Thacker; Lilah Besser; Brian D Plikaytis; Thomas H Taylor; Alison E Freeman; Kelly J Wallace; Peter Dull; Jim Sejvar; Erica Bruce; Rosa Moreno; Anne Schuchat; Jairam R Lingappa; Sandra K Martin; John Walls; Melinda Bronsdon; George M Carlone; Mary Bajani-Ari; David A Ashford; David S Stephens; Bradley A Perkins
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.